Fig. 5From: De Novo Rational design of peptide-based covalent inhibitors via mapping of complementary binding site residues – technical protocol and case study on KRASG12C and BTK481CSystemic computational workflow for the de novo design of peptide-based covalent inhibitorsBack to article page